Viking Therapeutics Inc. (VKTX)
25.71
-3.16 (-10.95%)
At close: Mar 03, 2025, 3:59 PM
25.70
-0.04%
After-hours: Mar 03, 2025, 07:58 PM EST
Viking Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -39.9 | -20.44 | -10.72 | -6.58 | -11.34 | -22.39 | -19.96 | -5.13 | -1.31 | -0.93 | -1.58 | -235.76 | -26.7 |
| PEG Ratio | -3.63 | -6 | -0.42 | -0.16 | -0.29 | 4.25 | 0.38 | 0.42 | 0.02 | 0.03 | -0.00 | 2.66 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 4.98 | 5.04 | 4.97 | 1.76 | 1.67 | 2.08 | 1.48 | 7.83 | 2.41 | 2.48 | -1.56 | -137.59 | -0.11 |
| P/FCF Ratio | -49.98 | -23.93 | -14.92 | -7.46 | -18.77 | -23.32 | -23.49 | -7.15 | -1.75 | -2.48 | -21.67 | -440.72 | -59.28 |
| P/OCF Ratio | -49.98 | -23.93 | -14.92 | -7.46 | -18.77 | -23.32 | -23.49 | -7.15 | -1.75 | -2.48 | -21.67 | -440.72 | -59.28 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | n/a | 0.26 | 0.41 | 0.25 | -0.07 | -1.11 | -0.41 |
| Quick Ratio | 33.09 | 19.19 | 7.61 | 23.98 | 21.12 | 41.83 | 66.40 | 2.52 | 2.16 | 7.69 | 0.03 | 1.41 | n/a |
| Current Ratio | 33.09 | 19.19 | 7.61 | 23.98 | 21.12 | 41.83 | 66.40 | 2.52 | 2.16 | 7.69 | 0.03 | 1.41 | n/a |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | -1.15K | n/a | -3.09K | -402.47 | -223.88 | -64.75 | -14.87 | -7.65 | -12.21 | -37.33 | -4.12 | n/a |
| Return on Equity (ROE) | -0.12 | -0.25 | -0.46 | -0.27 | -0.15 | -0.09 | -0.07 | -1.53 | -1.83 | -2.68 | 0.99 | 0.58 | 0.00 |
| Return on Assets (ROA) | -0.12 | -0.23 | -0.4 | -0.26 | -0.14 | -0.09 | -0.07 | -0.93 | -1.01 | -1.52 | -7.19 | -0.81 | n/a |
| Return on Capital (ROIC) | -0.17 | -0.29 | -0.48 | -0.28 | -0.17 | -0.12 | -0.09 | -1.42 | -1.72 | -0.89 | 1.21 | -1.91 | 0.01 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |